5lmy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:45, 9 April 2025) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
==Solution structure of the m-pmv myristoylated matrix protein==
==Solution structure of the m-pmv myristoylated matrix protein==
-
<StructureSection load='5lmy' size='340' side='right' caption='[[5lmy]], [[NMR_Ensembles_of_Models | 15 NMR models]]' scene=''>
+
<StructureSection load='5lmy' size='340' side='right'caption='[[5lmy]]' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[5lmy]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LMY OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5LMY FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[5lmy]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Mason-Pfizer_monkey_virus Mason-Pfizer monkey virus]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5LMY OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5LMY FirstGlance]. <br>
-
</td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 15 models</td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5lmy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lmy OCA], [http://pdbe.org/5lmy PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5lmy RCSB], [http://www.ebi.ac.uk/pdbsum/5lmy PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5lmy ProSAT]</span></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MYR:MYRISTIC+ACID'>MYR</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5lmy FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5lmy OCA], [https://pdbe.org/5lmy PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5lmy RCSB], [https://www.ebi.ac.uk/pdbsum/5lmy PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5lmy ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/GAG_MPMV GAG_MPMV]] p10 is the matrix protein. P14 is the nucleocapsid protein. p27 is the capsid protein.
+
[https://www.uniprot.org/uniprot/GAG_MPMV GAG_MPMV] p10 is the matrix protein. P14 is the nucleocapsid protein. p27 is the capsid protein.
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
-
We determined the solution structure of myristoylated Mason-Pfizer monkey virus matrix protein by NMR spectroscopy. The myristoyl group is buried inside the protein and causes a slight reorientation of the helices. This reorientation leads to the creation of a binding site for phosphatidylinositols. The interaction between the matrix protein and phosphatidylinositols carrying C(8) fatty acid chains was monitored by observation of concentration-dependent chemical shift changes of the affected amino acid residues, a saturation transfer difference experiment and changes in (31)P chemical shifts. No differences in the binding mode or affinity were observed with differently phosphorylated phosphatidylinositols. The structure of the matrix protein-phosphatidylinositol-(4,5)-bisphosphate [PI(4,5)P(2)] complex was then calculated with HADDOCK software based on the intermolecular nuclear Overhauser enhancement contacts between the ligand and the matrix protein obtained from a (13)C-filtered/(13)C-edited nuclear Overhauser enhancement spectroscopy experiment. PI(4,5)P(2) binding was not strong enough for triggering of the myristoyl-switch. The structural changes of the myristoylated matrix protein were also found to result in a drop in the oligomerization capacity of the protein.
+
Matrix proteins play a key role in the transport of retroviral proteins inside infected cells and in the interaction with cellular membranes. In most retroviruses, retroviral matrix proteins are N-terminally myristoylated. This modification serves as a membrane targeting signal and also as an anchor for the membrane interaction. The aim of this work was to characterize interactions anchoring retroviral matrix protein at the plasma membrane of infected cell. To address this issue, we compared the structures and membrane affinity of the Mason-Pfizer monkey virus (M-PMV) wild-type matrix protein with its two budding deficient double mutants, i.e. T41I/T78I and Y28F/Y67F. The structures of the mutants were determined using solution NMR spectroscopy and their interactions with water-soluble phospholipids were studied. Water-soluble phospholipids are widely used models for studying membrane interactions by solution NMR spectroscopy. However, this approach might lead to artificial results due to unnatural hydrophobic interactions. Therefore, we used a new approach based on the measurement of the loss of the 1H NMR signal intensity of the protein sample induced by the addition of the liposomes containing phospholipids with naturally long fatty acids. HIV-1 matrix protein was used as a positive control because its ability to interact with liposomes has already been described. We found that in contrast to HIV-1, the M-PMV matrix protein interacted with the liposomes differently and much weaker. In our in-vivo experiments, the M-PMV matrix protein did not co-localize with lipid rafts. Therefore, we concluded that M-PMV might adopt different membrane binding mechanism than HIV-1.
-
The Structure of Myristoylated Mason-Pfizer Monkey Virus Matrix Protein and the Role of Phosphatidylinositol-(4,5)-Bisphosphate in Its Membrane Binding.,Prchal J, Srb P, Hunter E, Ruml T, Hrabal R J Mol Biol. 2012 Aug 2. PMID:22863803<ref>PMID:22863803</ref>
+
Membrane interactions of the Mason-Pfizer monkey virus matrix protein and its budding deficient mutants.,Kroupa T, Langerova H, Dolezal M, Prchal J, Spiwok V, Hunter E, Rumlova M, Hrabal R, Ruml T J Mol Biol. 2016 Oct 7. pii: S0022-2836(16)30425-9. doi:, 10.1016/j.jmb.2016.10.010. PMID:27725181<ref>PMID:27725181</ref>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
Line 22: Line 23:
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Hrabal, R]]
+
[[Category: Large Structures]]
-
[[Category: Prchal, J]]
+
[[Category: Mason-Pfizer monkey virus]]
-
[[Category: M-pmv]]
+
[[Category: Hrabal R]]
-
[[Category: Matrix]]
+
[[Category: Prchal J]]
-
[[Category: Myristoylated]]
+
-
[[Category: Retrovirus]]
+
-
[[Category: Viral protein]]
+

Current revision

Solution structure of the m-pmv myristoylated matrix protein

PDB ID 5lmy

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools